97292-73-4

Upstream product

• 6195-45-5 DL-2,3,4,5,6-penta-O-benzyl-myo-inositol 
• 26276-99-3 rac-1,4,5,6-tetra-O-benzyl-myo-inositol 
• 114218-29-0 (+/-)-1-O-allyl-2,3,4,5,6-pentakis-O-benzyl myo-inositol 
• 22144-57-6 DL-2,3,4,5,6-Penta-O-benzyl-2,3,5/4,6-pentahydroxycyclohexanone 
• 6691-27-6 (+/-)-cis-1,2-O-cyclohexylidene-3,4,5,6-tetrakis-O-benzyl myo-inositol 
• 10583-42-3 (+/-)-1-O-allyl-3,4,5,6-tetrakis-O-benzyl myo-inositol 
• 6763-47-9 rac-1,2-O-cyclohexylidene-myo-inositol 
• 87-89-8 D-myo-inositol 
• 130277-48-4 DL-1,2,3,4,5-Penta-O-benzyl-6-methylidenecyclohexane-1,2,4/3,5-pentol 

Downstream Products

• 125214-70-2 C₄₂H₄₃BrO₅ 
• 125214-71-3 (1R,3R,4R,5S)-2,3,4,8-Tetrakis-benzyloxy-6-oxa-bicyclo[3.2.1]octane 

Relevant academic research and scientific papers

The synthesis of DL-1-(hexadecanoyloxy)methyl- and 1-O-hexadecanoyl-inositols as potential inhibitors of phospholipase C

The synthesis of racemic analogues of phosphatidylinositol (PI) and phosphatidylinositol 4,5-bisphosphate (PIP2) starting from myo-inositol is described. Inositol derivatives with and without homologation at C(1) and with and without ionic grou